Is PSPC or JNJ a better dividend investment in 2026?

PSPC currently yields 19.55% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: PSPC offers higher current income.

What is the dividend yield difference between PSPC and JNJ?

PSPC has a forward dividend yield of 19.55% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 17.41 percentage points.

Home › Compare › PSPC vs JNJ

PSPC vs JNJ: Dividend Comparison 2026

PSPC yields 19.55% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PSPC wins by $40.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

PSPC

● Live price

19.55%

Share price

$10.23

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$71.0K

Annual income

$6,421.32

Full PSPC calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — PSPC vs JNJ

📍 PSPC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PSPC	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PSPC + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PSPC pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PSPC

Annual income on $10K today (after 15% tax)

$1,661.78/yr

After 10yr DRIP, annual income (after tax)

$5,458.12/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, PSPC beats the other by $1,420.72/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PSPC + JNJ for your $10,000?

PSPC: 50%JNJ: 50%

100% JNJ50/50100% PSPC

Portfolio after 10yr

$50.7K

Annual income

$5,585.60/yr

Blended yield

11.01%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PSPC

No analyst data

Altman Z

20.1

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PSPC buys

JNJ buys

No recent congressional trades found for PSPC or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPSPCJNJ

Forward yield	19.55% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$71.0K ✓	$30.5K
Annual income after 10y	$6,421.32 ✓	$4,749.88
Total dividends collected	$39.9K ✓	$15.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: PSPC vs JNJ ($10,000, DRIP)

Year	PSPC Portfolio	PSPC Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,655	$1,955.03	$10,594	$274.49	+$2.1K → PSPC
2	$15,853	$2,312.25	$11,294	$360.69	+$4.6K → PSPC
3	$19,670	$2,707.08	$12,133	$476.91	+$7.5K → PSPC
4	$24,186	$3,139.11	$13,156	$635.42	+$11.0K → PSPC
5	$29,486	$3,607.30	$14,432	$854.61	+$15.1K → PSPC
6	$35,660	$4,110.13	$16,056	$1,162.76	+$19.6K → PSPC
7	$42,802	$4,645.56	$18,175	$1,604.53	+$24.6K → PSPC
8	$51,010	$5,211.16	$21,009	$2,252.68	+$30.0K → PSPC
9	$60,384	$5,804.11	$24,911	$3,229.73	+$35.5K → PSPC
10	$71,033	$6,421.32	$30,458	$4,749.88	+$40.6K → PSPC

PSPC vs JNJ: Complete Analysis 2026

PSPC — Stock

Post Holdings Partnering Corporation does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, and similar partnering transaction with one or more businesses. Post Holdings Partnering Corporation was incorporated in 2021 and is based in Saint Louis, Missouri.

Full PSPC Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this PSPC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PSPC vs SCHD PSPC vs JEPI PSPC vs O PSPC vs KO PSPC vs MAIN PSPC vs ABBV PSPC vs MRK PSPC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.